Today: 11 June 2026
Freeport-McMoRan stock today: FCX edges up as copper rebounds toward record highs
30 December 2025
1 min read

Freeport-McMoRan stock today: FCX edges up as copper rebounds toward record highs

NEW YORK, December 30, 2025, 2:22 PM ET — Regular session

  • Freeport-McMoRan shares were higher in afternoon trading as copper prices bounced back.
  • Copper futures climbed after a sharp prior-session drop, keeping the metal near year-end highs.
  • Traders are watching whether copper holds near record levels into the turn of the year.

Freeport-McMoRan shares rose about 0.5% to $51.75 in afternoon trading on Tuesday, after swinging between $50.87 and $52.67 earlier in the session.

The move matters because Freeport’s earnings tend to track copper prices closely. When the metal rises, miners typically see higher revenue per pound sold, which can lift cash generation.

Copper’s year-end rally has put the spotlight back on supply tightness and demand tied to electrification and the buildout of power-hungry data centers. That backdrop has helped keep interest in large, liquid copper names such as Freeport.

U.S. Comex copper futures were up about 3.7% at roughly $5.77 a pound, reversing part of Monday’s decline, data showed.

On the London Metal Exchange, the day-delayed three-month copper closing price was $12,222 a metric ton, up 0.49%, according to the exchange’s published data.

Copper touched a record $12,960 per ton on Monday and is up 42% so far this year, Business Insider reported. “When the group starts to move, they all move together,” Art Hogan, chief market strategist at B. Riley Wealth Management, told the outlet, pointing to a broader metals rally that has kept copper in focus. Business Insider

Other miners were also firmer in U.S. trading, with Southern Copper up about 0.7%, BHP up about 1.3% and Rio Tinto up about 0.7%.

Copper has risen more than 35% in 2025 and has traded above $12,000 a ton this month as investors weighed shortage fears and a weaker dollar, the Guardian reported.

Phoenix-based Freeport is one of the world’s biggest publicly traded copper producers, with mining operations spanning the Americas and Indonesia. Because copper is its core business, the stock often acts as a stand-in — or proxy — for the metal’s price.

Traders said the next test is whether copper can hold near record levels after the new-year turn, with inventories and signs of Chinese demand in focus. The U.S. dollar will also matter, because a stronger dollar can weigh on commodities priced in U.S. currency.

For Freeport, the market will be looking for any fresh signals on production and cost trends as higher copper prices reset expectations for miners’ margins. Moves in copper, rather than company-specific headlines, have been setting the tone for the stock in recent sessions.

Stock Market Today

  • Johnson Controls International (JCI) Valuation Review Amid Recent Share Decline
    June 11, 2026, 10:52 AM EDT. Johnson Controls International (NYSE:JCI) shares fell 5.7% recently, despite solid annual revenue of US$24.4 billion and net income of US$2 billion. The stock trades slightly above its fair value estimate of US$138.11, which factors in a 9.38% discount rate and modest revenue growth forecast of 5.56%. Analyst models reflect steadier revenue expansion and improved profit margins, yet caution remains due to potential operational disruptions from a new segment structure and execution risks related to cost-saving initiatives. Investors are urged to evaluate both risks and rewards amid the short-term price weakness and maintain a close watch on ongoing financial performance and strategic execution.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
AMD stock today: Shares tick higher after hours as year-end tech selling weighs on chipmakers
Previous Story

AMD stock today: Shares tick higher after hours as year-end tech selling weighs on chipmakers

Nvidia stock dips after AI21 Labs talk report as NVDA investors size up Intel stake
Next Story

Nvidia stock dips after AI21 Labs talk report as NVDA investors size up Intel stake

Go toTop